SCP
ARQT icon

Silverleafe Capital Partners’s Arcutis Biotherapeutics ARQT Stock Holding History

Silverleafe Capital Partners’s Portfolio ARQT Stock Details ARQT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q2 		$203K Sell
14,500
-11,708
-45% -$164K 0.07% 84
2025
Q1 		$410K Buy
+26,208
New +$410K 0.14% 59